Avastin as effective as Eylea for treating central retinal vein occlusion
Avastin as effective as Eylea for treating central retinal vein occlusion
http://ift.tt/2psBUi1
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion (CRVO), according to a clinical trial funded by the National Eye Institute (NEI), part of the National Institutes of Health. After six monthly injections, treatment with either drug improved visual acuity on average from 20/100 to 20/40.
Singularity
via http://ift.tt/orfraw
May 9, 2017 at 06:42AM
http://ift.tt/2psBUi1
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion (CRVO), according to a clinical trial funded by the National Eye Institute (NEI), part of the National Institutes of Health. After six monthly injections, treatment with either drug improved visual acuity on average from 20/100 to 20/40.
Singularity
via http://ift.tt/orfraw
May 9, 2017 at 06:42AM
Treatment of Retinal Vein Occlusion depends on their type and severity, and can consist of laser treatment, drug injections or a vitrectomy. A BRVO may not need any treatment, and may heal itself given time. A CRVO, on the other hand, may involve immediate treatment.
ReplyDelete